These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

973 related articles for article (PubMed ID: 25889215)

  • 1. The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.
    Morris G; Berk M
    BMC Med; 2015 Apr; 13():68. PubMed ID: 25889215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.
    Morris G; Berk M; Walder K; Maes M
    BMC Med; 2015 Feb; 13():28. PubMed ID: 25856766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies associated with psychiatric disorders.
    Margutti P; Delunardo F; Ortona E
    Curr Neurovasc Res; 2006 May; 3(2):149-57. PubMed ID: 16719797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimmunologic influences in neuropsychiatric and psychophysiologic disorders.
    Fricchione G; Daly R; Rogers MP; Stefano GB
    Acta Pharmacol Sin; 2001 Jul; 22(7):577-87. PubMed ID: 11749820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial involvement in psychiatric disorders.
    Shao L; Martin MV; Watson SJ; Schatzberg A; Akil H; Myers RM; Jones EG; Bunney WE; Vawter MP
    Ann Med; 2008; 40(4):281-95. PubMed ID: 18428021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis.
    Morris G; Stubbs B; Köhler CA; Walder K; Slyepchenko A; Berk M; Carvalho AF
    Sleep Med Rev; 2018 Oct; 41():255-265. PubMed ID: 29759891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction and psychiatric disorders.
    Rezin GT; Amboni G; Zugno AI; Quevedo J; Streck EL
    Neurochem Res; 2009 Jun; 34(6):1021-9. PubMed ID: 18979198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mini-review: Brain energy metabolism and its role in animal models of depression, bipolar disorder, schizophrenia and autism.
    Kolar D; Kleteckova L; Brozka H; Vales K
    Neurosci Lett; 2021 Aug; 760():136003. PubMed ID: 34098028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders.
    Streck EL; Gonçalves CL; Furlanetto CB; Scaini G; Dal-Pizzol F; Quevedo J
    Braz J Psychiatry; 2014; 36(2):156-67. PubMed ID: 24845118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposed mechanism for autism: an aberrant neuroimmune response manifested as a psychiatric disorder.
    Buehler MR
    Med Hypotheses; 2011 Jun; 76(6):863-70. PubMed ID: 21421290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.
    Valenti D; de Bari L; De Filippis B; Henrion-Caude A; Vacca RA
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():202-17. PubMed ID: 24548784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Dysfunctions in Bipolar Disorder: Effect of the Disease and Pharmacotherapy.
    Cikankova T; Sigitova E; Zverova M; Fisar Z; Raboch J; Hroudova J
    CNS Neurol Disord Drug Targets; 2017; 16(2):176-186. PubMed ID: 27978794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model of the mitochondrial basis of bipolar disorder.
    Morris G; Walder K; McGee SL; Dean OM; Tye SJ; Maes M; Berk M
    Neurosci Biobehav Rev; 2017 Mar; 74(Pt A):1-20. PubMed ID: 28093238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage and repair in neuropsychiatric disorders. What do we know and what are the future perspectives?
    Czarny P; Bialek K; Ziolkowska S; Strycharz J; Sliwinski T
    Mutagenesis; 2020 Feb; 35(1):79-106. PubMed ID: 31676908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.
    Clay HB; Sillivan S; Konradi C
    Int J Dev Neurosci; 2011 May; 29(3):311-24. PubMed ID: 20833242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant Action on Mitochondrial Dysfunction in Psychiatric Disorders.
    Adzic M; Brkic Z; Bulajic S; Mitic M; Radojcic MB
    Drug Dev Res; 2016 Nov; 77(7):400-406. PubMed ID: 27539538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways.
    Maes M; Kubera M; Obuchowiczwa E; Goehler L; Brzeszcz J
    Neuro Endocrinol Lett; 2011; 32(1):7-24. PubMed ID: 21407167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimmune mechanisms in health and disease: 2. Disease.
    Anisman H; Baines MG; Berczi I; Bernstein CN; Blennerhassett MG; Gorczynski RM; Greenberg AH; Kisil FT; Mathison RD; Nagy E; Nance DM; Perdue MH; Pomerantz DK; Sabbadini ER; Stanisz A; Warrington RJ
    CMAJ; 1996 Oct; 155(8):1075-82. PubMed ID: 8873636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.